MedTrace Logo

Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention

NCT02684344 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2019-01-23

Study results available
· View outcomes & findings →

Summary

This randomized open-label study will be comprised of 2 cohorts: one control group and one treatment group. The trial will be conducted as an open label randomized trial to evaluate the efficacy of tamsulosin in the prevention of post-operative urinary retention. The study will include pre- and post-surgical evaluations of patients including symptoms of urinary retention and any adverse effects contributable to the study medication.

Conditions

  • Post-Operative Urinary Retention

Interventions

DRUG

Tamsulosin

Tamsulosin may have prophylactic properties against post-operative urinary retention

OTHER

Education

Education about signs and symptoms of urinary retention

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Edward E. Messing, MD · University of Rochester

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2017-12-31
Completion
2017-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02684344 on ClinicalTrials.gov